PURPLE BIOTECH LTD's ticker is PPBT and the CUSIP is 74638P109. A total of 19 filers reported holding PURPLE BIOTECH LTD in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,144 | -71.7% | 20,125 | -65.6% | 0.00% | – |
| Q2 2023 | $81,822 | -16.8% | 58,444 | +4.6% | 0.00% | – |
| Q1 2023 | $98,340 | -37.1% | 55,875 | -50.7% | 0.00% | – |
| Q4 2022 | $156,444 | -6.9% | 113,365 | +37.2% | 0.00% | – |
| Q3 2022 | $168,000 | +175.4% | 82,600 | +221.4% | 0.00% | – |
| Q2 2022 | $61,000 | -64.9% | 25,704 | -41.4% | 0.00% | – |
| Q1 2022 | $174,000 | -27.2% | 43,900 | -28.7% | 0.00% | – |
| Q4 2021 | $239,000 | -15.5% | 61,600 | -0.8% | 0.00% | – |
| Q3 2021 | $283,000 | -57.7% | 62,100 | -54.7% | 0.00% | – |
| Q2 2021 | $669,000 | +108.4% | 136,977 | +76.3% | 0.00% | – |
| Q1 2021 | $321,000 | – | 77,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 346,197 | $1,319,000 | 0.01% |
| Virtu Financial LLC | 22,988 | $88,000 | 0.01% |
| WASHINGTON TRUST BANK | 16,454 | $63,000 | 0.01% |
| TRUE Private Wealth Advisors | 6,700 | $25,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,800 | $110,000 | 0.00% |
| Your Advocates Ltd., LLP | 400 | $2,000 | 0.00% |
| Renaissance Technologies | 128,900 | $491,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| North Star Investment Management Corp. | 300 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 26,167 | $100,000 | 0.00% |